Neurocrine Bioscience buy Guggenheim
Start price
06.05.26
/
50%
€123.15
Target price
06.05.27
€149.31
Performance (%)
25.98%
Price
19:26
€155.15
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 25.98%. This prediction currently runs until 06.05.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 3.516% | 3.516% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its "buy" rating reaffirmed by Guggenheim. They now have a $175.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€157.15
21.07.26
21.07.26
€175.28
21.07.27
21.07.27
-1.27%
19:26
19:26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€146.09
06.05.26
06.05.26
14.56%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€120.00
10.02.25
10.02.25
€157.98
10.02.26
10.02.26
-2.54%
11.02.26
11.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25